You are currently viewing MACULAR DEGENERATION

MACULAR DEGENERATION

Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth

AUTHORS:

 

Abstract

The subretinal transplantation of retinal pigment epithelial cells (RPE cells) grown on polymeric supports may have interest in retinal diseases affecting RPE cells. In this study, montmorillonite based polyurethane nanocomposite (PU-NC) was investigated as substrate for human RPE cell growth (ARPE-19 cells). The ARPE-19 cells were seeded on the PU-NC, and cell viability, proliferation and differentiation were investigated. The results indicated that ARPE-19 cells attached, proliferated onto the PU-NC, and expressed occludin. The in vivo ocular biocompatibility of the PU-NC was assessed by using the HET-CAM; and through its implantation under the retina. The direct application of the nanocomposite onto the CAM did not compromise the vascular tissue in the CAM surface, suggesting no ocular irritancy of the PU-NC film. The nanocomposite did not elicit any inflammatory response when implanted into the eye of rats. The PU-NC may have potential application as a substrate for RPE cell transplantation.

What does it have to do with ANMODE Health?

We have started several trials with various conditions of Macular Degeneration by utilizing HEKA DETOX.  At this point in time it is far too early to have definite answers, but we feel encouraged.

More Information

https://www.prnewswire.com/news-releases/lorati-successfully-develops-effective-treatment-for-stargardt-disease-using-eye-drops-300804051.html

https://www.karger.com/Article/Abstract/357361

https://patents.google.com/patent/US20170128403A1/en

Leave a Reply